Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 11829208)

1.
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
3.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
4.

Amisulpride: progress and outcomes.

Lecrubier Y.

Curr Med Res Opin. 2002;18 Suppl 3:s18-22. Review.

PMID:
12418608
5.

Clinical update on amisulpride in deficit schizophrenia.

Rein W, Turjanski S.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S19-27. Review.

PMID:
9218164
6.

[Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].

Pélissolo A, Krebs MO, Olié JP.

Encephale. 1996 May-Jun;22(3):215-9. Review. French.

PMID:
8767050
7.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
8.

Safety profile of amisulpride in short- and long-term use.

Rein W, Coulouvrat C, Dondey-Nouvel L.

Acta Psychiatr Scand Suppl. 2000;400:23-7. Review.

PMID:
10823308
9.

Amisulpride: a review of its efficacy in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 2000;400:17-22. Review.

PMID:
10823307
10.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
11.

Amisulpride: a review of its use in the management of schizophrenia.

Curran MP, Perry CM.

Drugs. 2001;61(14):2123-50. Review.

PMID:
11735643
12.

Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride.

Saleem P, Olié JP, Loo H.

Int Clin Psychopharmacol. 2002 Jan;17(1):1-8. Review.

PMID:
11806403
13.

Focus on amisulpride.

Green B.

Curr Med Res Opin. 2002;18(3):113-7. Review.

PMID:
12094819
14.

Spotlight on amisulpride in schizophrenia.

Curran MP, Perry CM.

CNS Drugs. 2002;16(3):207-11. Review.

PMID:
11888341
15.

Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.

Kasper S.

Int Clin Psychopharmacol. 2002 Dec;17 Suppl 4:S19-26. Review.

PMID:
12685918
16.

How do we choose between atypical antipsychotics? The advantages of amisulpride.

Mortimer AM.

Int J Neuropsychopharmacol. 2004 Mar;7 Suppl 1:S21-5. Review.

PMID:
14972081
17.

Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.

Zink M, Knopf U, Henn FA, Thome J.

Pharmacopsychiatry. 2004 Jan;37(1):26-31. Review.

PMID:
14750045
18.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
19.

Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia.

Lecrubier Y, Azorin M, Bottai T, Dalery J, Garreau G, Lempérière T, Lisoprawski A, Petitjean F, Vanelle JM.

Neuropsychobiology. 2001;44(1):41-6. Review.

PMID:
11408792
20.

Clinical implications of dopamine research in schizophrenia.

Pani L.

Curr Med Res Opin. 2002;18 Suppl 3:s3-7. Review.

PMID:
12418605
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk